MarketCap
Facebook
X
TelegramIntec Pharma Ltd ROA | NTEC
ROA Jährlich Intec Pharma Ltd
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|
| -67.61 | -223.68 | -70.79 | -45.07 | -54.05 | -19.22 | - | - | - | - |
Jährliche Entwicklung
Kennzahlen zur Anzeige auswählen
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| -19.22 | -223.68 | -80.07 |
ROA anderer Aktien in der Pharmaeinzelhändler
| Name | ROA | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
Институт стволовых клеток человека
ISKJ
|
4.82 | - | - | - |  Russia |
 |
Lyra Therapeutics
LYRA
|
-80.09 | - | - | $ 24.9 M |  USA |
 |
Brickell Biotech
BBI
|
-49.15 | - | -5.38 % | $ 6.06 M | USA |
 |
Applied Therapeutics
APLT
|
-121.84 | - | - | $ 8.42 M | USA |
 |
ESSA Pharma
EPIX
|
-22.28 | - | - | $ 8.86 M |  Canada |
 |
Generation Bio Co.
GBIO
|
-56.95 | - | - | $ 344 M | USA |
 |
Clearside Biomedical
CLSD
|
-136.72 | - | - | $ 25.3 M | USA |
 |
Merus N.V.
MRUS
|
-27.51 | - | - | $ 5.78 B |  Niderland |
 |
RAPT Therapeutics
RAPT
|
-54.04 | - | - | $ 2.36 B | USA |
 |
Annexon
ANNX
|
-74.47 | $ 4.2 | -0.36 % | $ 651 M | USA |
 |
AbbVie
ABBV
|
1.36 | $ 294.72 | 0.32 % | $ 521 B | USA |
 |
Galmed Pharmaceuticals Ltd.
GLMD
|
-55.34 | $ 4.63 | 21.05 % | $ 20 M |  Israel |
 |
Avenue Therapeutics
ATXI
|
-99.25 | - | -52.27 % | $ 4.45 M | USA |
 |
Achieve Life Sciences
ACHV
|
-130.77 | $ 6.78 | 0.89 % | $ 296 M | USA |
 |
Axon Enterprise
AXON
|
1.78 | $ 316.97 | 4.77 % | $ 24.7 B | USA |
 |
TFF Pharmaceuticals
TFFP
|
-176.62 | - | -60.05 % | $ 125 K | USA |
 |
Bristol-Myers Squibb Company
BMY
|
7.83 | $ 62.89 | 0.18 % | $ 128 B | USA |
 |
Adaptimmune Therapeutics plc
ADAP
|
-28.79 | - | -15.15 % | $ 60.3 M |  Britain |
 |
Axcella Health
AXLA
|
-428.94 | - | -16.42 % | $ 249 M | USA |
 |
Cytokinetics, Incorporated
CYTK
|
-55.1 | $ 58.59 | 4.29 % | $ 7.04 M | USA |
 |
Dynavax Technologies Corporation
DVAX
|
2.77 | - | - | $ 2.02 B | USA |
 |
Alnylam Pharmaceuticals
ALNY
|
6.32 | $ 159.75 | 5.35 % | $ 20.9 B | USA |
 |
Amgen
AMGN
|
8.51 | $ 467.97 | 0.59 % | $ 252 B | USA |
 |
Orgenesis
ORGS
|
-3565.14 | - | -33.86 % | $ 61.2 M | USA |
 |
Codiak BioSciences
CDAK
|
-21.64 | - | -55.98 % | $ 2.15 M | USA |
 |
Jazz Pharmaceuticals plc
JAZZ
|
-3.05 | $ 248.31 | 1.17 % | $ 15.1 B |  Irlanda |
 |
Johnson & Johnson
JNJ
|
13.46 | $ 280.31 | -0.17 % | $ 675 B | USA |
 |
Kala Pharmaceuticals
KALA
|
-284.3 | $ 0.17 | 0.64 % | $ 1.39 M | USA |
 |
BioLineRx Ltd.
BLRX
|
-4.95 | $ 1.49 | -1.97 % | $ 3.67 B | Israel |
 |
Sage Therapeutics
SAGE
|
-73.22 | - | - | $ 527 M | USA |
 |
Can-Fite BioPharma Ltd.
CANF
|
-103.3 | $ 1.59 | -2.76 % | $ 2.62 M | Israel |
 |
Lineage Cell Therapeutics
LCTX
|
-56.43 | $ 1.13 | 8.17 % | $ 260 M | USA |
 |
Paratek Pharmaceuticals
PRTK
|
-36.84 | - | - | $ 121 M | USA |
 |
TCR2 Therapeutics
TCRR
|
-72.91 | - | - | $ 58.1 M | USA |
 |
C4 Therapeutics
CCCC
|
-29.24 | $ 2.9 | -3.5 % | $ 240 M | USA |
 |
Eli Lilly and Company
LLY
|
18.35 | $ 1 437.4 | 0.36 % | $ 1.29 T | USA |
 |
ASLAN Pharmaceuticals Limited
ASLN
|
-179.56 | - | -14.27 % | $ 1.7 M |  Singapore |
 |
Compugen Ltd.
CGEN
|
22.57 | $ 2.09 | -0.24 % | $ 195 M | Israel |
 |
Adverum Biotechnologies
ADVM
|
-72.8 | - | - | $ 86.2 M | USA |
 |
Crinetics Pharmaceuticals
CRNX
|
-41.31 | $ 84.95 | 0.13 % | $ 7.99 B | USA |
 |
GeoVax Labs
GOVX
|
-338.46 | $ 2.13 | -20.4 % | $ 2.04 M | USA |
 |
Unity Biotechnology
UBX
|
-69.01 | - | -33.41 % | $ 3.37 M | USA |
 |
MediciNova
MNOV
|
26.31 | $ 1.41 | 0.36 % | $ 69.2 M | USA |
 |
AVEO Pharmaceuticals
AVEO
|
-6.89 | - | - | $ 521 M | USA |
 |
Seelos Therapeutics
SEEL
|
-699.19 | - | -47.76 % | $ 6.27 M | USA |
 |
Celldex Therapeutics
CLDX
|
-44.38 | $ 30.18 | -1.53 % | $ 2 B | USA |
 |
Moderna
MRNA
|
-22.87 | $ 248.62 | -0.88 % | $ 96.7 B | USA |